Mehrotra R, Devuyst O, Davies SJ, Johnson DW (2016) The current state of peritoneal dialysis. J Am Soc Nephrol 27(11):3238. https://doi.org/10.1681/ASN.2016010112
Article CAS PubMed PubMed Central Google Scholar
Davies SJ, Bryan J, Phillips L, Russell GI (1996) Longitudinal changes in peritoneal kinetics: the effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc 11(3):498–506
Yung S, Chan TM (2012) Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cells. Mediat Inflamm 2012:484167. https://doi.org/10.1155/2012/484167
Alfano G, Frisina M, Morisi N et al (2021) Methicillin-resistant Staphylococcus aureus peritonitis due to hematogenous dissemination from central venous catheter in a maintenance dialysis patient. CASE Rep Nephrol Dial 11:281–285. https://doi.org/10.1159/000517143
Article PubMed PubMed Central Google Scholar
Cho Y, Johnson DW (2014) Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis 64(2):278–289. https://doi.org/10.1053/j.ajkd.2014.02.025
Cangini G, Rusolo D, Cappuccilli M, Donati G, La Manna G (2019) Evolution of the concept of quality of life in the population in end stage renal disease: a systematic review of the literature. Clin Ter 170(4):e301–e320. https://doi.org/10.7417/CT.2019.2152
Article CAS PubMed Google Scholar
Boudville N, Kemp A, Clayton P et al (2012) Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol JASN 23(8):1398–1405. https://doi.org/10.1681/ASN.2011121135
Fabbian F, De Giorgi A, Ferrara F et al (2023) Comorbidity and in-hospital mortality in peritoneal dialysis patients: data of the Emilia Romagna region of Italy. Eur Rev Med Pharmacol Sci 27(14):6867–6875. https://doi.org/10.26355/eurrev_202307_33158
Article CAS PubMed Google Scholar
Cortés-Sanabria L, Rodríguez-Arreola BE, Ortiz-Juárez VR et al (2013) Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis. Perit Dial Int J Int Soc Perit Dial 33(6):679–686. https://doi.org/10.3747/pdi.2011.00274
Marshall MR (2022) A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit Dial Int J Int Soc Perit Dial 42(1):39–47. https://doi.org/10.1177/0896860821996096
Tobijaszewska M, Martus G, Sunnerhagen T, Segelmark M, Ljungquist O (2024) A population-based study on the incidence and aetiology of infectious complications in peritoneal dialysis in South Sweden. Infect Dis 56(3):230–243. https://doi.org/10.1080/23744235.2023.2292133
Okpechi IG, Ekrikpo U, Moloi MW, Noubiap JJ, Okpechi-Samuel US, Bello AK (2020) Prevalence of peritonitis and mortality in patients with ESKD treated with chronic peritoneal dialysis in Africa: a systematic review. BMJ Open 10(12):e039970. https://doi.org/10.1136/bmjopen-2020-039970
Article PubMed PubMed Central Google Scholar
Li PKT, Chow KM, Cho Y et al (2022) ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int 42(2):110–153. https://doi.org/10.1177/08968608221080586
Nessim SJ, Bargman JM, Austin PC, Story K, Jassal SV (2009) Impact of age on peritonitis risk in peritoneal dialysis patients: an era effect. Clin J Am Soc Nephrol CJASN 4(1):135–141. https://doi.org/10.2215/CJN.02060508
Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV (2009) Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol CJASN 4(7):1195–1200. https://doi.org/10.2215/CJN.00910209
Ljungman S, Jensen JE, Paulsen D et al (2023) Factors associated with time to first dialysis-associated peritonitis episode: data from the Peritonitis Prevention Study (PEPS). Perit Dial Int 43(3):241–251. https://doi.org/10.1177/08968608231161179
Article CAS PubMed Google Scholar
Troidle L, Watnick S, Wuerth DB, Gorban-Brennan N, Kliger AS, Finkelstein FO (2003) Depression and its association with peritonitis in long-term peritoneal dialysis patients. Am J Kidney Dis 42(2):350–354. https://doi.org/10.1016/S0272-6386(03)00661-9
Ueda R, Nakao M, Maruyama Y et al (2019) Effect of diabetes on incidence of peritoneal dialysis-associated peritonitis. PLoS ONE 14(12):e0225316. https://doi.org/10.1371/journal.pone.0225316
Article CAS PubMed PubMed Central Google Scholar
Wang Q, Bernardini J, Piraino B, Fried L (2003) Albumin at the start of peritoneal dialysis predicts the development of peritonitis. Am J Kidney Dis 41(3):664–669. https://doi.org/10.1053/ajkd.2003.50128
Article CAS PubMed Google Scholar
Chow KM, Li PKT, Cho Y et al (2023) ISPD catheter-related infection recommendations: 2023 Update. Perit Dial Int J Int Soc Perit Dial 43(3):201–219. https://doi.org/10.1177/08968608231172740
Grothe C, Taminato M, Belasco A, Sesso R, Barbosa D (2016) Prophylactic treatment of chronic renal disease in patients undergoing peritoneal dialysis and colonized by Staphylococcus aureus: a systematic review and meta-analysis. BMC Nephrol 17(1):115. https://doi.org/10.1186/s12882-016-0329-0
Article CAS PubMed PubMed Central Google Scholar
Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GF (2017) Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2017(4):CD004679. https://doi.org/10.1002/14651858.CD004679.pub3
Article PubMed Central Google Scholar
Mupirocin Study Group (1996) Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. J Am Soc Nephrol JASN 7(11):2403–2408. https://doi.org/10.1681/ASN.V7112403
Piraino B, Perlmutter JA, Holley JL, Bernardini J (1993) Staphylococcus aureus peritonitis is associated with Staphylococcus aureus nasal carriage in peritoneal dialysis patients. Perit Dial Int 13(2_suppl):232–335. https://doi.org/10.1177/089686089301302S82
Pérez-Fontán M, García-Falcón T, Rosales M et al (1993) Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis Off J Natl Kidney Found 22(5):708–712. https://doi.org/10.1016/s0272-6386(12)80434-3
Govindarajulu S, Hawley CM, McDonald SP et al (2010) Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 30(3):311–319. https://doi.org/10.3747/pdi.2008.00258
Bunke CM, Brier ME, Golper TA (1997) Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the network 9 peritonitis study. Kidney Int 52(2):524–529. https://doi.org/10.1038/ki.1997.363
Article CAS PubMed Google Scholar
Piewngam P, Otto M (2024) Staphylococcus aureus colonisation and strategies for decolonisation. Lancet Microbe 5(6):e606–e618. https://doi.org/10.1016/S2666-5247(24)00040-5
Reagan DR, Doebbeling BN, Pfaller MA et al (1991) Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 114(2):101–106. https://doi.org/10.7326/0003-4819-114-2-101
Article CAS PubMed Google Scholar
Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D’Agata EMC (2003) Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 37(12):1629–1638. https://doi.org/10.1086/379715
Article CAS PubMed Google Scholar
Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V (2000) The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial Conf Perit Dial 16:257–261
Comments (0)